Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance
Ron C.J. Schackmann, … , Jos Jonkers, Patrick W.B. Derksen
Ron C.J. Schackmann, … , Jos Jonkers, Patrick W.B. Derksen
Published July 11, 2011
Citation Information: J Clin Invest. 2011;121(8):3176-3188. https://doi.org/10.1172/JCI41695.
View: Text | PDF
Research Article Oncology

Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance

  • Text
  • PDF
Abstract

Metastatic breast cancer is the major cause of cancer-related death among women in the Western world. Invasive carcinoma cells are able to counteract apoptotic signals in the absence of anchorage, enabling cell survival during invasion and dissemination. Although loss of E-cadherin is a cardinal event in the development and progression of invasive lobular carcinoma (ILC), little is known about the underlying mechanisms that govern these processes. Using a mouse model of human ILC, we show here that cytosolic p120-catenin (p120) regulates tumor growth upon loss of E-cadherin through the induction of anoikis resistance. p120 conferred anchorage independence by indirect activation of Rho/Rock signaling through interaction and inhibition of myosin phosphatase Rho–interacting protein (Mrip), an antagonist of Rho/Rock function. Consistent with these data, primary human ILC samples expressed hallmarks of active Rock signaling, and Rock controlled the anoikis resistance of human ILC cells. Thus, we have linked loss of E-cadherin — an initiating event in ILC development — to Rho/Rock-mediated control of anchorage-independent survival. Because activation of Rho and Rock are strongly linked to cancer progression and are susceptible to pharmacological inhibition, these insights may have clinical implications for the development of tailor-made intervention strategies to better treat invasive and metastatic lobular breast cancer.

Authors

Ron C.J. Schackmann, Miranda van Amersfoort, Judith H.I. Haarhuis, Eva J. Vlug, Vincentius A. Halim, Jeanine M.L. Roodhart, Joost S. Vermaat, Emile E. Voest, Petra van der Groep, Paul J. van Diest, Jos Jonkers, Patrick W.B. Derksen

×

Figure 6

Active Rock signaling contributes to growth and survival of human ILC.

Options: View larger image (or click on image) Download as PowerPoint
Active Rock signaling contributes to growth and survival of human ILC.
(...
(A) Human ILC samples were stained for phosphorylated cofilin and phosphorylated MLC by immunohistochemistry. Insets show the effect of λ-phosphatase treatment, indicating specificity of the antibodies. Scale bars: 30 μm. (B) SKBR-3 and primary hILC-3 cells were cultured in the absence of anchorage and treated with 10 μM Y-27632. After 4 days, anoikis resistance (n = 3) and growth speed (n = 6) were determined. Error bars represent SD of triplicate measurements. *P < 0.005. (C) SKBR-3 and primary hILC-3 cells were transduced with viruses carrying shRNA sequences against human p120. Cells were stained for DNA using DAPI (blue), p120 (red), and p-MLC (green). Arrowheads, nontransduced cells; arrows, transduced p120-KD cells. Note the reduction in phosphorylated MLC upon p120 KD. Scale bars: 5 μm. (D) SKBR-3 and hILC-3 cells were transduced with viruses carrying HA-tagged Mrip. Cells were stained for DNA using DAPI (blue), HA (red), and p-MLC (green). Arrows, HA-Mrip–expressing cells; arrowheads, nontransduced cells. Scale bars: 5 μm.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts